Microbiology

  1. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies

    1. Scott M. Matushek
    2. Kathleen G. Beavis
    3. Ana Abeleda
    4. Cindy Bethel
    5. Carlissa Hunt
    6. Stephanie Gillen
    7. Angelica Moran
    8. Vera Tesic

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. In Vitro Inhibition of SARS-CoV-2 Infection by Bovine Lactoferrin

    1. Carlos Alberto Marques de Carvalho
    2. Aline da Rocha Matos
    3. Braulia Costa Caetano
    4. Ivanildo Pedro de Sousa Junior
    5. Samir Pereira da Costa Campos
    6. Barbara Rodrigues Geraldino
    7. Caroline Augusto Barros
    8. Matheus Augusto Patricio de Almeida
    9. Vanessa Pimenta Rocha
    10. Andréa Marques Vieira da Silva
    11. Juliana Gil Melgaço
    12. Patrícia Cristina da Costa Neves
    13. Tamiris Azamor da Costa Barros
    14. Ana Paula Dinis Ano Bom
    15. Marilda Mendonça Siqueira
    16. Sotiris Missailidis
    17. Rafael Braga Gonçalves

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Comparison of SARS-CoV-2 Indirect and Direct Detection Methods

    1. Joel D. Pearson
    2. Daniel Trcka
    3. Sharon J. Hyduk
    4. Marie-Ming Aynaud
    5. J. Javier Hernández
    6. Filippos Peidis
    7. Suying Lu
    8. Kin Chan
    9. Jim Woodgett
    10. Tony Mazzulli
    11. Liliana Attisano
    12. Laurence Pelletier
    13. Myron I. Cybulsky
    14. Jeffrey L. Wrana
    15. Rod Bremner

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Antibody repertoire induced by SARS-CoV-2 spike protein immunogens

    1. Supriya Ravichandran
    2. Elizabeth M. Coyle
    3. Laura Klenow
    4. Juanjie Tang
    5. Gabrielle Grubbs
    6. Shufeng Liu
    7. Tony Wang
    8. Hana Golding
    9. Surender Khurana

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. CoV3D: a database of high resolution coronavirus protein structures

    1. Ragul Gowthaman
    2. Johnathan D Guest
    3. Rui Yin
    4. Jared Adolf-Bryfogle
    5. William R Schief
    6. Brian G Pierce

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

    1. Philip J.M. Brouwer
    2. Tom G. Caniels
    3. Karlijn van der Straten
    4. Jonne L. Snitselaar
    5. Yoann Aldon
    6. Sandhya Bangaru
    7. Jonathan L. Torres
    8. Nisreen M.A. Okba
    9. Mathieu Claireaux
    10. Gius Kerster
    11. Arthur E.H. Bentlage
    12. Marlies M. van Haaren
    13. Denise Guerra
    14. Judith A. Burger
    15. Edith E. Schermer
    16. Kirsten D. Verheul
    17. Niels van der Velde
    18. Alex van der Kooi
    19. Jelle van Schooten
    20. Mariëlle J. van Breemen
    21. Tom P. L. Bijl
    22. Kwinten Sliepen
    23. Aafke Aartse
    24. Ronald Derking
    25. Ilja Bontjer
    26. Neeltje A. Kootstra
    27. W. Joost Wiersinga
    28. Gestur Vidarsson
    29. Bart L. Haagmans
    30. Andrew B. Ward
    31. Godelieve J. de Bree
    32. Rogier W. Sanders
    33. Marit J. van Gils

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Potential antiviral options against SARS-CoV-2 infection

    1. Aleksandr Ianevski
    2. Rouan Yao
    3. Mona Høysæter Fenstad
    4. Svetlana Biza
    5. Eva Zusinaite
    6. Tuuli Reisberg
    7. Hilde Lysvand
    8. Kirsti Løseth
    9. Veslemøy Malm Landsem
    10. Janne Fossum Malmring
    11. Valentyn Oksenych
    12. Sten Even Erlandsen
    13. Per Arne Aas
    14. Lars Hagen
    15. Caroline H. Pettersen
    16. Tanel Tenson
    17. Jan Egil Afset
    18. Svein Arne Nordbø
    19. Magnar Bjørås
    20. Denis E. Kainov

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution

    1. Atreyee Basu
    2. Tatyana Zinger
    3. Kenneth Inglima
    4. Kar-mun Woo
    5. Onome Atie
    6. Lauren Yurasits
    7. Benjamin See
    8. Maria E. Aguero-Rosenfeld

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells: Nafamostat is the most potent antiviral drug candidate

    1. Meehyun Ko
    2. Sangeun Jeon
    3. Wang-Shick Ryu
    4. Seungtaek Kim

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunity

    1. Niko Kohmer
    2. Sandra Westhaus
    3. Cornelia Rühl
    4. Sandra Ciesek
    5. Holger F. Rabenau

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 65 of 252 Next